Bio Operating Margin from 2010 to 2026
| TECH Stock | USD 66.78 0.92 1.40% |
Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 M, Total Revenue of 1.5 B or Gross Profit of 954.3 M, as well as many indicators such as Price To Sales Ratio of 6.86, Dividend Yield of 0.0106 or PTB Ratio of 6.72. Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.
Bio | Operating Margin | Build AI portfolio with Bio Stock |
The Operating Margin trend for Bio Techne Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Bio Techne is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Bio Techne's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Bio Techne Corp over the last few years. It is Bio Techne's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Techne's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.18 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Bio Operating Margin Regression Statistics
| Arithmetic Mean | 0.25 | |
| Geometric Mean | 0.20 | |
| Coefficient Of Variation | 59.18 | |
| Mean Deviation | 0.11 | |
| Median | 0.22 | |
| Standard Deviation | 0.15 | |
| Sample Variance | 0.02 | |
| Range | 0.4804 | |
| R-Value | (0.61) | |
| Mean Square Error | 0.01 | |
| R-Squared | 0.37 | |
| Significance | 0.01 | |
| Slope | (0.02) | |
| Total Sum of Squares | 0.34 |
Bio Operating Margin History
About Bio Techne Financial Statements
Investors use fundamental indicators, such as Bio Techne's Operating Margin, to determine how well the company is positioned to perform in the future. Although Bio Techne's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota. Bio-Techne operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3000 people.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Bio Techne Correlation against competitors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is there potential for Life Sciences Tools & Services market expansion? Will Bio introduce new products? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.091 | Dividend Share 0.16 | Earnings Share 0.53 | Revenue Per Share | Quarterly Revenue Growth (0) |
Understanding Bio Techne Corp requires distinguishing between market price and book value, where the latter reflects Bio's accounting equity. The concept of intrinsic value - what Bio Techne's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Bio Techne's price substantially above or below its fundamental value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Bio Techne's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.